Labcorp (LH) Tops Q3 EPS by 5c, Offers FY25 EPS Guidance

Go back to Labcorp (LH) Tops Q3 EPS by 5c, Offers FY25 EPS Guidance

Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted'

October 28, 2025 1:09 PM EDT

Leerink Partners analyst Michael Cherny reiterated an Outperform rating and $342.00 price target on Laboratory Corporation of America (NYSE: LH).

The analyst comments "We remain positive on LH and view the pronounced weakness post-Q as an opportunity for a durable compounder at a more appealing valuation. As we... More